HOME PROPERTIES ALERT – National Securities Law Firm Seeks Higher Price for Home Properties Shareholders in Connection with its Acquisition, and Encourages Shareholders to Contact Law Firm for More Information.
June 22, 2015
New York, New York
Tripp Levy PLLC, a leading national securities and shareholder rights law firm, announces that it is investigating the acquisition of Home Properties, Inc. (NYSE: HME) (“Home” or the “Company”) on behalf of its shareholders. Home announced that it has entered into a definitive agreement to be acquired by an affiliate of Lone Star Funds. Under the terms of the merger agreement, Lone Star Funds will acquire all of the outstanding common stock of Home for $75.23 per share in an all-cash transaction.
Our investigation has determined that price of only $75.23 per share unfairly under-values the true going forward inherent value of Home and that shareholders are not receiving the maximum value for their shares. Indeed, at least one analyst has opined that the Company is worth at least $79 per share, and the stock traded as high as $77.53 this past year. The investigation further seeks to determine whether the senior management of Home is entering into this deal for their own self-interests to the detriment of the Company’s shareholders.
If you are a shareholder of Home and would like additional information as to how the acquisition may affect your rights as a shareholder, and how you may be eligible to obtain a higher price for your shares, please contact us toll free at 1-800-511-7037 or contact us via our website.
Tripp Levy PLLC represents individual and institutional shareholders in mergers and acquisitions transactions and, along with its affiliate, has recovered billions of dollars for shareholders in securities actions around the globe. Tripp Levy PLLC is affiliated with the law firm Milberg LLP. The National Law Journal has named Milberg one of the “50 Elite Trial Lawyer Firms” and one of the “50 Leading Plaintiff Firms in America.” Attorney advertising. Prior results do not indicate a similar outcome.